Artificial Tears Market Trend Shows Outstanding Growth at a CAGR of 5.5% by 2030 | Exactitude Consultancy
The Exactitude Consultancy has updated its global market reports with latest data for 2024 and projections up to 2030
LUTON, BEDFORDSHIRE, UNITED KINGDOM, April 3, 2024 /EINPresswire.com/ -- The global artificial tears market size is projected to grow from USD 2.89 billion in 2023 to USD 4.20 billion by 2030, exhibiting a CAGR of 5.5% during the forecast period.
Artificial tears refer to a wide range of lubricating eye products which are often administered to the patients to relieve the symptoms of dryness in eyes and irritation of ocular surface. Artificial tears are especially critical as an ophthalmic treatment as a significant proportion of the global population is suffering from the problem of dry eye syndrome and other ocular problems such as eye allergies. As a significant proportion is over the counter products, it can be self-administered and further reduces the additional economic burden on the healthcare system. This has led to the increasing presence of numerous companies in the R&D initiatives for these products leading to launches of more sophisticated versions of eye drops, aiding global market growth during the forecast period.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐧 𝐏𝐃𝐅 𝐅𝐨𝐫𝐦𝐚𝐭:
https://exactitudeconsultancy.com/reports/41377/artificial-tears-market/#request-a-sample
𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞:
Major players in the Artificial Tears Market are identified through secondary research and their market revenues determined through primary and secondary research are: Allergan,Bausch + Lomb,Novartis AG,Johnson & Johnson,Alcon,Santen Pharmaceutical Co., Ltd.,Ocusoft, Inc.,Thea Pharmaceuticals,Akorn Pharmaceuticals,Similasan Corporation,Visine,Prestige Consumer Healthcare Inc.,Bayer AG,Ophthalmic Specialty Group,Rohto Pharmaceutical Co., Ltd.,TheraTears,OCuSOFT Inc.,Scope Ophthalmics Ltd.,Laboratoires Théa,SIFI S.p.A., among others.
𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:
January 2022, Alcon Inc launched systane artificial tear drops in Europe, which are completely preservative-free lubricant eye drops.
November 2022, Allergan plc is going to acquire Kythera Biopharmaceuticals at USD 75 per Kythera share, which is approximately USD 2.1 billion.
𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐓𝐞𝐚𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:
Artificial Tears Market 𝗯𝘆 𝗧𝘆𝗽𝗲
Polyethylene Glycols and Polypropylene Glycols
Cellulose
Other
Artificial Tears Market 𝗯𝘆 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗠𝗲𝘁𝗵𝗼𝗱
Eye Drops
Ointments
𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬
𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗽𝗿𝗶𝗺𝗮𝗿𝘆 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗧𝗲𝗮𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁?
𝖱𝗂𝗌𝗂𝗇𝗀 𝖯𝗋𝖾𝗏𝖺𝗅𝖾𝗇𝖼𝖾 𝗈𝖿 𝖣𝗋𝗒 𝖤𝗒𝖾 𝖣𝗂𝗌𝖾𝖺𝗌𝖾
The rising incidence of dry eye syndrome, which is anticipated to increase demand for the market, is one of the main factors driving the global market. Despite the fact that dry eye syndrome is not a disorder that poses a life-threatening risk, it does affect the quality of life for those who have it. In many nations around the world, the prevalence of dry eye syndrome has been estimated, with the prevalence ranging between 9.5 and 90%, according to a report published in the research journal BMC Ophthalmology in January 2020. Such trends and statistical data have shown that there are many current and potential patients worldwide who are becoming more aware of this disorder. Even though this condition may not have a serious impact on the patient's vision, it frequently leads to a markedly reduced quality of life for the patient. This is anticipated to further accelerate market growth over the course of the projection period.
𝖨𝗇𝖼𝗋𝖾𝖺𝗌𝗂𝗇𝗀 𝖨𝗇𝗍𝖾𝗋𝗇𝖾𝗍 𝖯𝖾𝗇𝖾𝗍𝗋𝖺𝗍𝗂𝗈𝗇
The increasing incidence of cataracts among the rapidly aging population globally is also positively impacting market growth. According to a recent clinical study in 2019 by the World Health Organization, cataracts are the most common reason for blindness and eye surgeries, accounting for about 47.8% of all blindness worldwide. Around 17.7 million people worldwide have had cataracts diagnosed. It is usual for patients to experience symptoms of dry eye syndrome after a few months following the cataract surgery. Thus, the demand for artificial tears is expected to increase among patients after cataract surgery.
𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗺𝗮𝗶𝗻 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝘁𝗵𝗮𝘁 𝘄𝗶𝗹𝗹 𝘀𝗹𝗼𝘄 𝗱𝗼𝘄𝗻 𝘁𝗵𝗲 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗧𝗲𝗮𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁?
𝖲𝗂𝖽𝖾 𝖤𝖿𝖿𝖾𝖼𝗍𝗌 𝗈𝖿 𝖠𝗋𝗍𝗂𝖿𝗂𝖼𝗂𝖺𝗅 𝗍𝖾𝖺𝗋𝗌
Some of the most important restrictions include product safety issues, which force users to use them with caution. Risks of contamination and unfavorable reactions from the product's preservatives are just a couple of the safety issues related to teardrops. Due to these safety concerns, usage is constrained, and the various ocular conditions may result in decreased productivity, which has a negative impact on quality of life. These restrictions are anticipated to reduce the demand for these goods, which can limit the market's expansion throughout the forecast period.
𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗧𝗲𝗮𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁?
𝖨𝗇𝖼𝗋𝖾𝖺𝗌𝗂𝗇𝗀 𝖳𝖾𝖼𝗁𝗇𝗈𝗅𝗈𝗀𝗂𝖼𝖺𝗅 𝖠𝖽𝗏𝖺𝗇𝖼𝖾𝗆𝖾𝗇𝗍𝗌
Consistent releases of cutting-edge and ground-breaking products from top businesses will also play a significant role in driving the global market during the forecast period. Such frequent releases of cutting-edge products have consistently raised patient population awareness. Sturdy demand for these products has resulted from this. The market's potential may be further increased by cutting-edge therapies and products for a variety of ocular conditions like dry eye syndrome and conjunctivitis. Recent launches from the SYSTANE family, like SYSTANE HYDRATION PF, and the Refresh family of artificial tears, like REFRESH RELIEVA, are two examples of recent launches that are anticipated to spur market growth during the forecast period.
𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐓𝐞𝐚𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬
One of the most critical trends in the global market for artificial tears is the strong consumer awareness of ocular diseases such as dry eye syndrome which diminishes the patient’s quality of life. This trend awareness of dry eye syndrome has been driven by the main companies involved in the production and also further boosted by critical governmental agencies. For instance, in the U.S., the month of July is celebrated as the ‘National Dry Eye Awareness Month’, an initiative that is supported by the country’s critical health agency, National Institutes of Health (NIH). Thus, such initiatives help in spreading awareness regarding the dry eye syndrome disease and measures that can be implemented to alleviate the disease effectively. Such trends are expected to significantly boost the sales of the market during the forecast period.
𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
North America region is the highest contributor to the market and is expected to grow at a healthy CAGR during the forecast period. This can be attributed to the high adoption of treatment therapies and the presence of a favorable reimbursement framework. Dry eye disease is one of the most prevalent conditions in the U.S., as nearly 30% of the U.S. population suffers from dry eye disease. This is further supported by increasing demand for LASIK and refractive surgeries and the high adoption of contact lenses. For instance, per CDC estimates, an estimated 45 million people wear contact lenses in the country, representing high demand for artificial tears. According to a report, there are roughly 16 million diagnosed cases of dry eye diseases in the United States, or 6.8% of the adult population. Compared to men, females are more likely to experience it. Because of dry eye disease, almost 60% of patients visit eye care professionals. It is anticipated that the prevalence of risk factors, such as systemic diseases (diabetes), high digital device usage, and an aging population, will continue to rise in the U.S.A.
𝐁𝐫𝐨𝐰𝐬𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐒𝐮𝐦𝐦𝐚𝐫𝐲 𝐚𝐧𝐝 𝐓𝐚𝐛𝐥𝐞 𝐨𝐟 𝐂𝐨𝐧𝐭𝐞𝐧𝐭:
https://exactitudeconsultancy.com/reports/41377/artificial-tears-market/
𝐅𝐫𝐞𝐪𝐮𝐞𝐧𝐭𝐥𝐲 𝐀𝐬𝐤𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬:
☑ What does this report covers?
☑ Does this report estimates the current market size?
☑ What are the key Segments offered in this report?
☑ Which market dynamics are covered in this report?
☑ Does this report offer customization?
𝐖𝐞 𝐨𝐟𝐟𝐞𝐫 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫’𝐬 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭:
– country-level analysis for the 5 countries of your choice.
– competitive analysis of 5 key market players.
– 40 free analyst hours to cover any other data point.
𝙎𝙚𝙚𝙠𝙞𝙣𝙜 𝘾𝙤𝙢𝙥𝙧𝙚𝙝𝙚𝙣𝙨𝙞𝙫𝙚 𝙄𝙣𝙩𝙚𝙡𝙡𝙞𝙜𝙚𝙣𝙘𝙚 𝙤𝙣 𝘿𝙞𝙛𝙛𝙚𝙧𝙚𝙣𝙩 𝙈𝙖𝙧𝙠𝙚𝙩𝙨? 𝙂𝙚𝙩 𝙞𝙣 𝙩𝙤𝙪𝙘𝙝 𝙬𝙞𝙩𝙝 𝙤𝙪𝙧 𝙚𝙭𝙥𝙚𝙧𝙩𝙨: 𝙎𝙥𝙚𝙖𝙠 𝙩𝙤 𝙖𝙣 𝙀𝙭𝙥𝙚𝙧𝙩: https://exactitudeconsultancy.com/primary-research/
𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐋𝐢𝐧𝐤𝐬:
https://exactitudeconsultancy.com/ja/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/de/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/ko/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/fr/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/zh-CN/reports/41377/artificial-tears-market/
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
𝐂𝐨𝐧𝐧𝐞𝐜𝐭 𝐔𝐬:
https://bulletin.exactitudeconsultancy.com/
Irfan T
Exactitude Consultancy
+1 704-266-3234
email us here
Visit us on social media:
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
